|
Delayed
Bombay S.E.
03:01:44 29/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,783.80 INR | -3.94% |
|
-2.75% | +13.02% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 49TCr 511.41Cr 449.79Cr 425.33Cr 385.78Cr 724.5Cr 728.71Cr 5.09TCr 1.97TCr 25TCr 1.92TCr 1.88TCr 80TCr | P/E 2027 * |
42.1x | P/E 2028 * | 36.6x |
|---|---|---|---|---|---|
| Enterprise Value | 49TCr 511.41Cr 449.79Cr 425.33Cr 385.78Cr 724.5Cr 728.71Cr 5.09TCr 1.97TCr 25TCr 1.92TCr 1.88TCr 80TCr | EV / Sales 2027 * |
11.5x | EV / Sales 2028 * | 10.4x |
| Free-Float |
24.37% | Yield 2027 * |
1.02% | Yield 2028 * | 1.02% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| GLAXO | Delayed | |
NSE India S.E.
| GLAXO | Delayed |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -3.63% | ||
| 1 week | -2.75% | ||
| Current month | -8.53% | ||
| 1 month | -8.53% | ||
| 3 months | +18.60% | ||
| 6 months | +22.30% | ||
| Current year | +13.02% |
| 1 week | 2,783.2 |  | 2,986.65 |
| 1 month | 2,758.35 | | 3,120.6 |
| Current year | 2,088 | | 3,121.1 |
| 1 year | 2,088 | | 3,121.1 |
| 3 years | 1,387.9 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
| Director/Board Member | 59 | 18/05/2020 | |
Manu Anand
BRD | Director/Board Member | 67 | 16/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.94% | -2.75% | +5.01% | +80.81% | 511.41Cr | |
| +0.11% | +1.71% | +63.52% | +117.61% | 1,05600Cr | |
| +0.27% | +0.92% | +51.33% | +73.35% | 66TCr | |
| +0.73% | +0.68% | +20.70% | +74.90% | 47TCr | |
| -0.77% | -3.16% | +37.68% | +40.79% | 34TCr | |
| +0.08% | +4.33% | +22.67% | +29.43% | 28TCr | |
| +1.59% | +0.35% | +14.68% | +14.54% | 26TCr | |
| +0.85% | +6.35% | +53.17% | +54.39% | 23TCr | |
| +0.85% | +1.10% | +35.78% | +101.82% | 19TCr | |
| -0.09% | -2.76% | -28.41% | -60.92% | 17TCr | |
| Average | -0.09% | +0.99% | +27.61% | +52.67% | 36.48TCr | |
| Weighted average by Cap. | +0.06% | +1.04% | +40.40% | +69.89% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4.26TCr 44Cr 39Cr 37Cr 33Cr 63Cr 63Cr 441.59Cr 170.55Cr 2.17TCr 166.49Cr 162.89Cr 6.98TCr | 4.72TCr 49Cr 43Cr 41Cr 37Cr 70Cr 70Cr 490.06Cr 189.27Cr 2.41TCr 184.77Cr 180.77Cr 7.75TCr |
| Net income | 1.17TCr 12Cr 11Cr 10Cr 9.16Cr 17Cr 17Cr 120.9Cr 47Cr 594.69Cr 46Cr 45Cr 1.91TCr | 1.34TCr 14Cr 12Cr 12Cr 11Cr 20Cr 20Cr 139.19Cr 54Cr 684.69Cr 52Cr 51Cr 2.2TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | ₹2,783.80 | -3.94% | 2,980 |
| 28/26/28 | ₹2,897.85 | +2.88% | 14,107 |
| 25/26/25 | ₹2,816.85 | -0.31% | 639 |
| 24/26/24 | ₹2,825.75 | -1.76% | 1,674 |
| 23/26/23 | ₹2,876.50 | +0.17% | 35,527 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
